echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Am J Clin Nutr: Multivitamin and Mineral Supplements Reduce Lung Cancer Risk in Older People!

    Am J Clin Nutr: Multivitamin and Mineral Supplements Reduce Lung Cancer Risk in Older People!

    • Last Update: 2022-04-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Multivitamin and mineral supplements (MVMs) typically provide ≥100% of the recommended daily intake of the most basic vitamins and minerals and are the most common dietary supplements in the United States and other high-income countries
    .


    Depending on the ingredients and purpose, MVMs can be divided into daily MVMs, potent MVMs, and dedicated MVMs


    Multivitamin and mineral supplements (MVMs) typically provide ≥100% of the recommended daily intake of the most basic vitamins and minerals and are the most common dietary supplements in the United States and other high-income countries


    This was a randomized, double-blind, placebo-controlled, 2x2 factorial clinical trial of 21,442 U.
    S.
    adults (12,666 women ≥65 years and 8776 men ≥60 years) with no significant Cardiovascular disease and cancer
    .


    Daily MVM and cocoa extract interventions were randomized between June 2015 and December 2020


    Incidence of aggressive cancer in both groups

    Incidence of aggressive cancer in both groups

    At 3.
    6 years of follow-up, 518 subjects in the MVM group and 535 subjects in the placebo group developed invasive cancer (hazard ratio [HR] 0.
    97, p=0.
    57)
    .


    Taking daily MVM had no significant effect on the risk of breast and colorectal cancer (HR 1.


    There were 518 and 535 subjects in the MVM and placebo groups, respectively, who developed aggressive cancer (hazard ratio [HR] 0.


    Cardiovascular disease hazard ratio between the two groups

    Cardiovascular disease hazard ratio between the two groups

    The composite cardiovascular disease endpoint (HR 0.
    98) occurred in 429 and 437 subjects in the MVM and placebo groups, respectively
    .


    In addition, daily MVM failed to significantly affect all-cause mortality (HR 0.


    Daily MVM failed to significantly affect all-cause mortality (HR 0.


    Compared with placebo, routine daily MVM supplementation reduced lung cancer risk in older adults, but not overall cancer risk and had no significant effect on cardiovascular disease risk


    Original source:

    Original source:

    Sesso Howard D, Rist Pamela M, Aragaki Aaron K et al.


    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.